Safety and efficacy of intravenous thrombolytic therapy in the extended window up to 24 hours: A systematic review and meta‐analysis
2024

Thrombolytic Therapy in the Extended Window

Sample size: 2221 publication Evidence: high

Author Information

Author(s): O. M. Al‐Janabi, Seyed Behnam Jazayeri, Michelle A. Toruno, Yamama M. Mahmood, Sherief Ghozy, Shadi Yaghi, Alejandro A. Rabinstein, David F. Kallmes

Primary Institution: Department of Neurology Baptist Health Lexington Kentucky USA

Hypothesis

This study is to elucidate the safety and efficacy of IVT in the extended therapeutic window (ETW) in patients with AIS.

Conclusion

The use of IVT in AIS in ETW is beneficial especially with the use of perfusion imaging for patients' selection.

Supporting Evidence

  • IVT showed higher rates of functional recovery at 90 days.
  • Rate of mortality at 90 days was not different between groups.
  • Rate of sICH was higher among the IVT group.

Takeaway

This study found that giving certain medications to stroke patients even after 4.5 hours can help them recover better, especially if doctors use special imaging to choose the right patients.

Methodology

A systematic review and meta-analysis of randomized controlled trials (RCTs) evaluating the safety and efficacy of intravenous thrombolytics for AIS treatment in the extended window.

Potential Biases

Moderate risk of bias in four studies, and high risk of bias in one study.

Limitations

Some studies had small sample sizes, and imaging criteria for inclusion and definitions of sICH differed across studies.

Participant Demographics

59% male, mean age ranged from 63 to 75 years.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI 1.1–1.34

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1002/acn3.52239

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication